JOHN P BILBREY
CIK 1268386 · Chairman, President and CEO · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$44.02M
Companies
8
Total Filings
259
Lifetime Open-Market Net
-$39.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLPX | Director | 0 | $2.07 | $0 | $661.0K | 8 | 2026-07-07 |
| CL | Director | 44,948 | $91.30 | $4.10M | -$1.75M | 62 | 2026-07-02 |
| ELAN | Director | 120,122 | $26.37 | $3.17M | $351.1K | 6 | 2024-12-03 |
| TPR | Director | 47,846 | $152.37 | $7.29M | $448.2K | 9 | 2024-11-15 |
| CPB | Director | 1,797 | $21.98 | $39.5K | $0 | 16 | 2023-09-29 |
| Elanco Animal Health Inc (ELAT) Delisted | Director | 81,579 | $21.32 | $1.74M | $646.0K | 28 | 2023-01-03 |
| HSY | Director | 162,491 | $175.05 | $28.44M | -$40.08M | 45 | 2018-04-03 |
| MKC.V | Director | 19,045 | $50.95 | $970.3K | $0 | 83 | 2015-04-23 |
Recent Filings · Page 2 of 26
259 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-06 | CL | Grant (A) | +228 | $21.2K | EDGAR |
| 2024-12-03 | ELAN | Grant (A) | +18,169 | $0 | EDGAR |
| 2024-11-19 | OLPX | Buy (P) | +76,825 | $134.7K | EDGAR |
| 2024-11-15 | TPR | Grant (A) | +3,459 | $200.0K | EDGAR |
| 2024-10-03 | CL | Grant (A) | +201 | $21.2K | EDGAR |
| 2024-08-21 | OLPX | Buy (P) | +183,493 | $376.2K | EDGAR |
| 2024-08-09 | OLPX | Grant (A) | +203,046 | $0 | EDGAR |
| 2024-07-03 | CL | Grant (A) | +222 | $21.2K | EDGAR |
| 2024-05-15 | CL | Grant (A) | +1,905 | $0 | EDGAR |
| 2024-05-03 | CL | Mixed | — | -$187.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.